Bottom line
JRTMX vs JRLUX: the short answer
JRTMX (2035 Lifetime Blend Portfolio) and JRLUX (2045 Lifetime Blend Portfolio) are both mutual funds.
Both charge the same expense ratio (0.57%).
Over five years, JRLUX returned +8.5% a year vs +7.0% for JRTMX.
Updated Nov 19, 2026
JRTMX vs JRLUX side by side
| JRTMX | JRLUX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | John Hancock | John Hancock |
| Category | Target-Date | Target-Date |
| Expense ratio | 0.57% | 0.57% |
| Annual cost per $10k | $57 | $57 |
| 10-yr cost on $10k (prospectus) | $1,207 | $1,186 |
| Max front load | — | — |
| 12b-1 fee | 0.25% | 0.25% |
| 1-yr return | +11.1% | +14.2% |
| 5-yr return (annualized) | +7.0% | +8.5% |
| 10-yr return (annualized) | +7.4% | +8.4% |
| Best quarter | +17.2% | +18.8% |
| Worst quarter | −18.3% | −20.6% |
| Net assets (fund) | $1.3B | $1.0B |
| Number of holdings | 34 | 29 |
| Portfolio turnover | 15% | 16% |
| Returns as of | Dec 31, 2024 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | JRTMX | JRLUX | Difference |
|---|---|---|---|
| 2024 | +11.1% | +14.2% | −3.1% |
| 2023 | +15.2% | +17.6% | −2.4% |
| 2022 | −17.9% | −18.2% | +0.3% |
| 2021 | +15.8% | +18.1% | −2.4% |
| 2020 | +15.1% | +15.9% | −0.8% |
| 2019 | +23.3% | +24.8% | −1.5% |
| 2018 | −7.8% | −8.5% | +0.7% |
| 2017 | +18.8% | +20.2% | −1.3% |
| 2016 | +10.1% | +10.4% | −0.2% |
| 2015 | −2.1% | −2.1% | +0.0% |
Source: Fund prospectus bar charts
Holdings overlap
23 of JRTMX's top 25 holdings also appear in JRLUX's top 25.
| Holding | JRTMX | JRLUX |
|---|---|---|
| John Hancock Funds II Multimanager 2010 Lifetime Portfolio | 24.71% | 28.95% |
| Natixis | 19.68% | 25.72% |
| Vanguard Total Bond Market ETF Vanguard Total Bond Market | 9.60% | 3.66% |
| Hancock John Sovereign Bd Fd Mutual Fund | 9.57% | 3.65% |
| VANGUARD SandP 500 ETF VANGUARD SandP 500 ETF | 7.56% | 13.19% |
| Fidelity Mid Cap Index Fund Fidelity Mid Cap Indx | 6.95% | 9.93% |
| Vanguard FTSE Developed Markets ETF | 5.98% | 5.47% |
| John Hancock Investors Trust | 2.84% | 1.28% |
| John Hancock Investors Trust | 2.19% | 0.96% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 1.96% | 2.78% |
| iShares MSCI Global Min Vol Factor ETF | 1.76% | 0.59% |
| Jh Collateral | 1.27% | 1.60% |
| Vanguard Dividend Appreciation Vanguard Dividend Apprec ETF | 1.19% | 0.54% |
| Vanguard Energy ETF Vanguard Energy ETF | 0.79% | 0.20% |
| Vanguard Real Estate ETF Vanguard Real Estate ETF | 0.74% | 0.19% |
Source: SEC Form N-PORT
JRTMX top 10
- John Hancock Funds II Multimanager 2010 Lifetime Portfolio — 24.71%
- Natixis — 19.68%
- Vanguard Total Bond Market ETF Vanguard Total Bond Market — 9.60%
- Hancock John Sovereign Bd Fd Mutual Fund — 9.57%
- VANGUARD SandP 500 ETF VANGUARD SandP 500 ETF — 7.56%
- Fidelity Mid Cap Index Fund Fidelity Mid Cap Indx — 6.95%
- Vanguard FTSE Developed Markets ETF — 5.98%
- John Hancock Investors Trust — 2.84%
- John Hancock Investors Trust — 2.19%
- Fidelity Salem Street Trust-Fidelity Small Cap Index Fund — 1.96%
JRLUX top 10
- John Hancock Funds II Multimanager 2010 Lifetime Portfolio — 28.95%
- Natixis — 25.72%
- VANGUARD SandP 500 ETF VANGUARD SandP 500 ETF — 13.19%
- Fidelity Mid Cap Index Fund Fidelity Mid Cap Indx — 9.93%
- Vanguard FTSE Developed Markets ETF — 5.47%
- Vanguard Total Bond Market ETF Vanguard Total Bond Market — 3.66%
- Hancock John Sovereign Bd Fd Mutual Fund — 3.65%
- Fidelity Salem Street Trust-Fidelity Small Cap Index Fund — 2.78%
- Jh Collateral — 1.60%
- Vanguard FTSE Emerging Markets Vanguard FTSE Emerging Marke — 1.58%
FAQ
What is the difference between JRTMX and JRLUX?
JRTMX (2035 Lifetime Blend Portfolio) and JRLUX (2045 Lifetime Blend Portfolio) are both mutual funds. Both charge the same expense ratio (0.57%).
Which is cheaper, JRTMX or JRLUX?
JRTMX has the lower expense ratio (0.57%).
Should I own both JRTMX and JRLUX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.